View in EDS

Peripheral Measurable Residual Disease Activity Assessment by MALDI-TOF Mass Spectrometry in Patients With Newly Diagnosed Multiple Myeloma in the Phase III GMMG-HD7 Trial.

Saved in:
Bibliographic Details
Title: Peripheral Measurable Residual Disease Activity Assessment by MALDI-TOF Mass Spectrometry in Patients With Newly Diagnosed Multiple Myeloma in the Phase III GMMG-HD7 Trial.
Authors: Jin JX; Heidelberg Myeloma Center, Internal Medicine V, Hematology, Oncology and Rheumatology, and German-speaking Myeloma Multicenter Group (GMMG), Heidelberg University Hospital and Medical Faculty Heidelberg, Heidelberg, Germany., Ginde VR; Division of Biostatistics, German Cancer Research Center (DKFZ), Heidelberg, Germany., Huhn S; Heidelberg Myeloma Center, Internal Medicine V, Hematology, Oncology and Rheumatology, and German-speaking Myeloma Multicenter Group (GMMG), Heidelberg University Hospital and Medical Faculty Heidelberg, Heidelberg, Germany.; National Center for Tumor Diseases Heidelberg, Heidelberg, Germany., Reichert P; Heidelberg Myeloma Center, Internal Medicine V, Hematology, Oncology and Rheumatology, and German-speaking Myeloma Multicenter Group (GMMG), Heidelberg University Hospital and Medical Faculty Heidelberg, Heidelberg, Germany.; National Center for Tumor Diseases Heidelberg, Heidelberg, Germany., Bertsch U; Heidelberg Myeloma Center, Internal Medicine V, Hematology, Oncology and Rheumatology, and German-speaking Myeloma Multicenter Group (GMMG), Heidelberg University Hospital and Medical Faculty Heidelberg, Heidelberg, Germany.; National Center for Tumor Diseases Heidelberg, Heidelberg, Germany., Fenk R; Department of Hematology, Oncology and Clinical Immunology, University Hospital Düsseldorf, Düsseldorf, Germany., Besemer B; Department of Internal Medicine II, University Hospital Tübingen, Tübingen, Germany., Boquoi A; Department for Hematology and Stem Cell Transplantation, University Hospital Essen, Essen, Germany., Schroers R; Department of Hematology and Oncology, Knappschaft Kliniken, Ruhr-University Bochum, Bochum, Germany., von Metzler I; Department of Medicine II-Hematology and Oncology, Goethe-University Frankfurt, University Hospital, Frankfurt am Main, Germany., Hänel M; Department of Internal Medicine III, Klinikum Chemnitz, Chemnitz, Germany., Mann C; Department for Hematology, Oncology and Immunology, University Hospital Gießen and Marburg, Marburg, Germany., Leypoldt LB; Department of Oncology, Hematology and BMT, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Heilmeier B; Clinic for Oncology and Hematology, Hospital Barmherzige Brueder Regensburg, Regensburg, Germany., Scheid C; Department of Internal Medicine I, University Hospital Cologne, Cologne, Germany., Peters-Regehr T; The Binding Site GmbH, part of Thermo Fisher Scientific, Schwetzingen, Germany., Blau IW; Medical Clinic, Charité University Medicine Berlin, Berlin, Germany., Müller-Tidow C; Heidelberg Myeloma Center, Internal Medicine V, Hematology, Oncology and Rheumatology, and German-speaking Myeloma Multicenter Group (GMMG), Heidelberg University Hospital and Medical Faculty Heidelberg, Heidelberg, Germany., Luntz S; Coordination Centre for Clinical Trials (KKS), University Hospital and Medical Faculty Heidelberg, Heidelberg, Germany., Holderried TAW; Department of Hematology, Oncology, Stem Cell Transplantation, Immune and Cell Therapy, Clinical Immunology and Rheumatology, University Hospital Bonn, Bonn, Germany.; Division of Hematology, Medical University of Graz, Graz, Austria., Trautmann-Grill K; Department of Internal Medicine I, University Hospital Dresden, TU Dresden, Germany., Gezer D; Department of Hematology, Oncology, Hemostaseology, and Stem Cell Transplantation, Faculty of Medicine, RWTH Aachen University, Aachen, Germany., Klaiber-Hakimi M; Clinic for Hematology, Oncology and Palliative Care, Marien Hospital Düsseldorf, Düsseldorf, Germany., Müller M; Clinic for Hematology, Oncology and Immunology, Klinikum Siloah Hannover, Hannover, Germany., Shumilov E; Department of Medicine A, Hematology, Oncology and Pneumology, University Hospital Münster, Münster, Germany., Knauf W; Center for Hematology and Oncology Bethanien, Frankfurt am Main, Germany., Michel CS; Department of Internal Medicine III, University Hospital Mainz, Mainz, Germany., Geer T; Department of Internal Medicine III, Diakoneo Clinic Schwäbisch-Hall, Schwäbisch-Hall, Germany., Riesenberg H; Hematology/Oncology Center, Bielefeld, Germany., Lutz C; Hematology/Oncology Center, Koblenz, Germany., Raab MS; Heidelberg Myeloma Center, Internal Medicine V, Hematology, Oncology and Rheumatology, and German-speaking Myeloma Multicenter Group (GMMG), Heidelberg University Hospital and Medical Faculty Heidelberg, Heidelberg, Germany., Weinhold N; Heidelberg Myeloma Center, Internal Medicine V, Hematology, Oncology and Rheumatology, and German-speaking Myeloma Multicenter Group (GMMG), Heidelberg University Hospital and Medical Faculty Heidelberg, Heidelberg, Germany., Hoffmann M; Medical Clinic A, Clinic Ludwigshafen, Ludwigshafen, Germany., Benner A; Division of Biostatistics, German Cancer Research Center (DKFZ), Heidelberg, Germany., Findeisen P; MVZ Labor Dr Limbach und Kollegen, Heidelberg, Germany., Weisel KC; Department of Oncology, Hematology and BMT, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Salwender HJ; Asklepios Tumorzentrum Hamburg, AK Altona and AK St Georg, Hamburg, Germany., Mai EK; Heidelberg Myeloma Center, Internal Medicine V, Hematology, Oncology and Rheumatology, and German-speaking Myeloma Multicenter Group (GMMG), Heidelberg University Hospital and Medical Faculty Heidelberg, Heidelberg, Germany., Goldschmidt H; Heidelberg Myeloma Center, Internal Medicine V, Hematology, Oncology and Rheumatology, and German-speaking Myeloma Multicenter Group (GMMG), Heidelberg University Hospital and Medical Faculty Heidelberg, Heidelberg, Germany.; National Center for Tumor Diseases Heidelberg, Heidelberg, Germany.
Corporate Authors: German-Speaking Myeloma Multicenter Group (GMMG) HD7 Investigators
Source: Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2026 May 21, pp. JCO2502957. Date of Electronic Publication: 2026 May 21.
Publication Type: Journal Article
Journal Info: Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-7755 (Electronic) Linking ISSN: 0732183X NLM ISO Abbreviation: J Clin Oncol Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 42166704
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Peripheral Measurable Residual Disease Activity Assessment by MALDI-TOF Mass Spectrometry in Patients With Newly Diagnosed Multiple Myeloma in the Phase III GMMG-HD7 Trial.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Jin+JX%22">Jin JX</searchLink>; Heidelberg Myeloma Center, Internal Medicine V, Hematology, Oncology and Rheumatology, and German-speaking Myeloma Multicenter Group (GMMG), Heidelberg University Hospital and Medical Faculty Heidelberg, Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Ginde+VR%22">Ginde VR</searchLink>; Division of Biostatistics, German Cancer Research Center (DKFZ), Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Huhn+S%22">Huhn S</searchLink>; Heidelberg Myeloma Center, Internal Medicine V, Hematology, Oncology and Rheumatology, and German-speaking Myeloma Multicenter Group (GMMG), Heidelberg University Hospital and Medical Faculty Heidelberg, Heidelberg, Germany.; National Center for Tumor Diseases Heidelberg, Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Reichert+P%22">Reichert P</searchLink>; Heidelberg Myeloma Center, Internal Medicine V, Hematology, Oncology and Rheumatology, and German-speaking Myeloma Multicenter Group (GMMG), Heidelberg University Hospital and Medical Faculty Heidelberg, Heidelberg, Germany.; National Center for Tumor Diseases Heidelberg, Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Bertsch+U%22">Bertsch U</searchLink>; Heidelberg Myeloma Center, Internal Medicine V, Hematology, Oncology and Rheumatology, and German-speaking Myeloma Multicenter Group (GMMG), Heidelberg University Hospital and Medical Faculty Heidelberg, Heidelberg, Germany.; National Center for Tumor Diseases Heidelberg, Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Fenk+R%22">Fenk R</searchLink>; Department of Hematology, Oncology and Clinical Immunology, University Hospital Düsseldorf, Düsseldorf, Germany.<br /><searchLink fieldCode="AU" term="%22Besemer+B%22">Besemer B</searchLink>; Department of Internal Medicine II, University Hospital Tübingen, Tübingen, Germany.<br /><searchLink fieldCode="AU" term="%22Boquoi+A%22">Boquoi A</searchLink>; Department for Hematology and Stem Cell Transplantation, University Hospital Essen, Essen, Germany.<br /><searchLink fieldCode="AU" term="%22Schroers+R%22">Schroers R</searchLink>; Department of Hematology and Oncology, Knappschaft Kliniken, Ruhr-University Bochum, Bochum, Germany.<br /><searchLink fieldCode="AU" term="%22von+Metzler+I%22">von Metzler I</searchLink>; Department of Medicine II-Hematology and Oncology, Goethe-University Frankfurt, University Hospital, Frankfurt am Main, Germany.<br /><searchLink fieldCode="AU" term="%22Hänel+M%22">Hänel M</searchLink>; Department of Internal Medicine III, Klinikum Chemnitz, Chemnitz, Germany.<br /><searchLink fieldCode="AU" term="%22Mann+C%22">Mann C</searchLink>; Department for Hematology, Oncology and Immunology, University Hospital Gießen and Marburg, Marburg, Germany.<br /><searchLink fieldCode="AU" term="%22Leypoldt+LB%22">Leypoldt LB</searchLink>; Department of Oncology, Hematology and BMT, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.<br /><searchLink fieldCode="AU" term="%22Heilmeier+B%22">Heilmeier B</searchLink>; Clinic for Oncology and Hematology, Hospital Barmherzige Brueder Regensburg, Regensburg, Germany.<br /><searchLink fieldCode="AU" term="%22Scheid+C%22">Scheid C</searchLink>; Department of Internal Medicine I, University Hospital Cologne, Cologne, Germany.<br /><searchLink fieldCode="AU" term="%22Peters-Regehr+T%22">Peters-Regehr T</searchLink>; The Binding Site GmbH, part of Thermo Fisher Scientific, Schwetzingen, Germany.<br /><searchLink fieldCode="AU" term="%22Blau+IW%22">Blau IW</searchLink>; Medical Clinic, Charité University Medicine Berlin, Berlin, Germany.<br /><searchLink fieldCode="AU" term="%22Müller-Tidow+C%22">Müller-Tidow C</searchLink>; Heidelberg Myeloma Center, Internal Medicine V, Hematology, Oncology and Rheumatology, and German-speaking Myeloma Multicenter Group (GMMG), Heidelberg University Hospital and Medical Faculty Heidelberg, Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Luntz+S%22">Luntz S</searchLink>; Coordination Centre for Clinical Trials (KKS), University Hospital and Medical Faculty Heidelberg, Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Holderried+TAW%22">Holderried TAW</searchLink>; Department of Hematology, Oncology, Stem Cell Transplantation, Immune and Cell Therapy, Clinical Immunology and Rheumatology, University Hospital Bonn, Bonn, Germany.; Division of Hematology, Medical University of Graz, Graz, Austria.<br /><searchLink fieldCode="AU" term="%22Trautmann-Grill+K%22">Trautmann-Grill K</searchLink>; Department of Internal Medicine I, University Hospital Dresden, TU Dresden, Germany.<br /><searchLink fieldCode="AU" term="%22Gezer+D%22">Gezer D</searchLink>; Department of Hematology, Oncology, Hemostaseology, and Stem Cell Transplantation, Faculty of Medicine, RWTH Aachen University, Aachen, Germany.<br /><searchLink fieldCode="AU" term="%22Klaiber-Hakimi+M%22">Klaiber-Hakimi M</searchLink>; Clinic for Hematology, Oncology and Palliative Care, Marien Hospital Düsseldorf, Düsseldorf, Germany.<br /><searchLink fieldCode="AU" term="%22Müller+M%22">Müller M</searchLink>; Clinic for Hematology, Oncology and Immunology, Klinikum Siloah Hannover, Hannover, Germany.<br /><searchLink fieldCode="AU" term="%22Shumilov+E%22">Shumilov E</searchLink>; Department of Medicine A, Hematology, Oncology and Pneumology, University Hospital Münster, Münster, Germany.<br /><searchLink fieldCode="AU" term="%22Knauf+W%22">Knauf W</searchLink>; Center for Hematology and Oncology Bethanien, Frankfurt am Main, Germany.<br /><searchLink fieldCode="AU" term="%22Michel+CS%22">Michel CS</searchLink>; Department of Internal Medicine III, University Hospital Mainz, Mainz, Germany.<br /><searchLink fieldCode="AU" term="%22Geer+T%22">Geer T</searchLink>; Department of Internal Medicine III, Diakoneo Clinic Schwäbisch-Hall, Schwäbisch-Hall, Germany.<br /><searchLink fieldCode="AU" term="%22Riesenberg+H%22">Riesenberg H</searchLink>; Hematology/Oncology Center, Bielefeld, Germany.<br /><searchLink fieldCode="AU" term="%22Lutz+C%22">Lutz C</searchLink>; Hematology/Oncology Center, Koblenz, Germany.<br /><searchLink fieldCode="AU" term="%22Raab+MS%22">Raab MS</searchLink>; Heidelberg Myeloma Center, Internal Medicine V, Hematology, Oncology and Rheumatology, and German-speaking Myeloma Multicenter Group (GMMG), Heidelberg University Hospital and Medical Faculty Heidelberg, Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Weinhold+N%22">Weinhold N</searchLink>; Heidelberg Myeloma Center, Internal Medicine V, Hematology, Oncology and Rheumatology, and German-speaking Myeloma Multicenter Group (GMMG), Heidelberg University Hospital and Medical Faculty Heidelberg, Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Hoffmann+M%22">Hoffmann M</searchLink>; Medical Clinic A, Clinic Ludwigshafen, Ludwigshafen, Germany.<br /><searchLink fieldCode="AU" term="%22Benner+A%22">Benner A</searchLink>; Division of Biostatistics, German Cancer Research Center (DKFZ), Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Findeisen+P%22">Findeisen P</searchLink>; MVZ Labor Dr Limbach und Kollegen, Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Weisel+KC%22">Weisel KC</searchLink>; Department of Oncology, Hematology and BMT, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.<br /><searchLink fieldCode="AU" term="%22Salwender+HJ%22">Salwender HJ</searchLink>; Asklepios Tumorzentrum Hamburg, AK Altona and AK St Georg, Hamburg, Germany.<br /><searchLink fieldCode="AU" term="%22Mai+EK%22">Mai EK</searchLink>; Heidelberg Myeloma Center, Internal Medicine V, Hematology, Oncology and Rheumatology, and German-speaking Myeloma Multicenter Group (GMMG), Heidelberg University Hospital and Medical Faculty Heidelberg, Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Goldschmidt+H%22">Goldschmidt H</searchLink>; Heidelberg Myeloma Center, Internal Medicine V, Hematology, Oncology and Rheumatology, and German-speaking Myeloma Multicenter Group (GMMG), Heidelberg University Hospital and Medical Faculty Heidelberg, Heidelberg, Germany.; National Center for Tumor Diseases Heidelberg, Heidelberg, Germany.
– Name: AuthorCorporate
  Label: Corporate Authors
  Group: Au
  Data: <searchLink fieldCode="CA" term="%22German-Speaking+Myeloma+Multicenter+Group+%28GMMG%29+HD7+Investigators%22">German-Speaking Myeloma Multicenter Group (GMMG) HD7 Investigators</searchLink>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%228309333%22">Journal of clinical oncology : official journal of the American Society of Clinical Oncology</searchLink> [J Clin Oncol] 2026 May 21, pp. JCO2502957. <i>Date of Electronic Publication: </i>2026 May 21.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Society+of+Clinical+Oncology%22">American Society of Clinical Oncology </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>8309333 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1527-7755 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%220732183X%22">0732183X </searchLink><i>NLM ISO Abbreviation: </i>J Clin Oncol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42166704
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1200/JCO-25-02957
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: JCO2502957
    Titles:
      – TitleFull: Peripheral Measurable Residual Disease Activity Assessment by MALDI-TOF Mass Spectrometry in Patients With Newly Diagnosed Multiple Myeloma in the Phase III GMMG-HD7 Trial.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Jin JX
      – PersonEntity:
          Name:
            NameFull: Ginde VR
      – PersonEntity:
          Name:
            NameFull: Huhn S
      – PersonEntity:
          Name:
            NameFull: Reichert P
      – PersonEntity:
          Name:
            NameFull: Bertsch U
      – PersonEntity:
          Name:
            NameFull: Fenk R
      – PersonEntity:
          Name:
            NameFull: Besemer B
      – PersonEntity:
          Name:
            NameFull: Boquoi A
      – PersonEntity:
          Name:
            NameFull: Schroers R
      – PersonEntity:
          Name:
            NameFull: von Metzler I
      – PersonEntity:
          Name:
            NameFull: Hänel M
      – PersonEntity:
          Name:
            NameFull: Mann C
      – PersonEntity:
          Name:
            NameFull: Leypoldt LB
      – PersonEntity:
          Name:
            NameFull: Heilmeier B
      – PersonEntity:
          Name:
            NameFull: Scheid C
      – PersonEntity:
          Name:
            NameFull: Peters-Regehr T
      – PersonEntity:
          Name:
            NameFull: Blau IW
      – PersonEntity:
          Name:
            NameFull: Müller-Tidow C
      – PersonEntity:
          Name:
            NameFull: Luntz S
      – PersonEntity:
          Name:
            NameFull: Holderried TAW
      – PersonEntity:
          Name:
            NameFull: Trautmann-Grill K
      – PersonEntity:
          Name:
            NameFull: Gezer D
      – PersonEntity:
          Name:
            NameFull: Klaiber-Hakimi M
      – PersonEntity:
          Name:
            NameFull: Müller M
      – PersonEntity:
          Name:
            NameFull: Shumilov E
      – PersonEntity:
          Name:
            NameFull: Knauf W
      – PersonEntity:
          Name:
            NameFull: Michel CS
      – PersonEntity:
          Name:
            NameFull: Geer T
      – PersonEntity:
          Name:
            NameFull: Riesenberg H
      – PersonEntity:
          Name:
            NameFull: Lutz C
      – PersonEntity:
          Name:
            NameFull: Raab MS
      – PersonEntity:
          Name:
            NameFull: Weinhold N
      – PersonEntity:
          Name:
            NameFull: Hoffmann M
      – PersonEntity:
          Name:
            NameFull: Benner A
      – PersonEntity:
          Name:
            NameFull: Findeisen P
      – PersonEntity:
          Name:
            NameFull: Weisel KC
      – PersonEntity:
          Name:
            NameFull: Salwender HJ
      – PersonEntity:
          Name:
            NameFull: Mai EK
      – PersonEntity:
          Name:
            NameFull: Goldschmidt H
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 21
              M: 05
              Text: 2026 May 21
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 1527-7755
          Titles:
            – TitleFull: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
              Type: main
ResultId 1